SignatureFD’s VivoSim Labs VIVS Stock Holding History

SignatureFD’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$4	–	3608
2025 Q4	$4	Hold	2	–	–	﹤0.01%	3398
2025 Q3	$6	Buy	+2	New	+$5	﹤0.01%	3372

Other funds holding VIVS

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Allworth Financial Folsom, California $23.6B AUM 20.99% 1-Year Est. Return

SignatureFD's VIVS Position: Q1 2026 in Review

SignatureFD sold out of VivoSim Labs (VIVS) in Q1 2026, closing a stake of 2 shares — an estimated $4 sold.

SignatureFD first reported a position in VIVS in Q3 2025 and held it in 2 quarters. The position peaked at $6 in Q3 2025. 24 funds tracked by Wall St. Rank hold VIVS as of Q1 2026.

SignatureFD reported no remaining VivoSim Labs position as of Q1 2026 after selling out during the quarter.
SignatureFD sold 2 VivoSim Labs shares in Q1 2026, an estimated $4.
SignatureFD first reported a position in VivoSim Labs in Q3 2025 and held it in 2 quarters.
SignatureFD's VivoSim Labs position peaked at $6 in Q3 2025.
24 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.